| Dr Puneet Victor Bansal, MD | |
|
121 Medical Center Dr Ste 3100, Brunswick, ME 04011-2672 | |
| (207) 406-7310 | |
| Not Available |
| Full Name | Dr Puneet Victor Bansal |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 13 Years |
| Location | 121 Medical Center Dr Ste 3100, Brunswick, Maine |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417230855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 60787 (Montana) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD25659 (Maine) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mid Coast Hospital | Brunswick, ME | Hospital |
| Lincolnhealth | Damariscotta, ME | Hospital |
| Maine Medical Center | Portland, ME | Hospital |
| Franklin Memorial Hospital | Farmington, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mainehealth | 7517860588 | 2067 |
News Archive
A promising new therapy for rheumatoid arthritis (RA) developed by researchers at the University of California, San Diego (UCSD) School of Medicine re-educates the body's immune system to prevent an attack against healthy joint tissue.
Coastal Contacts Inc. today announced that it has entered into a loan agreement with the Bank of America for a $5 million secured revolving line of credit.
The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK's Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today (09 February 2011).
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its intention to sell US$500 million of senior unsecured notes due 2021 issued by Fresenius Medical Care US Finance, Inc. and €300 million of senior unsecured notes due 2021 issued by FMC Finance VII S.A..
Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads — metastasizes — in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.
› Verified 3 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
A promising new therapy for rheumatoid arthritis (RA) developed by researchers at the University of California, San Diego (UCSD) School of Medicine re-educates the body's immune system to prevent an attack against healthy joint tissue.
Coastal Contacts Inc. today announced that it has entered into a loan agreement with the Bank of America for a $5 million secured revolving line of credit.
The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK's Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today (09 February 2011).
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its intention to sell US$500 million of senior unsecured notes due 2021 issued by Fresenius Medical Care US Finance, Inc. and €300 million of senior unsecured notes due 2021 issued by FMC Finance VII S.A..
Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads — metastasizes — in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Puneet Victor Bansal, MD 121 Medical Center Dr Ste 3100, Brunswick, ME 04011-2672 Ph: (207) 406-7310 | Dr Puneet Victor Bansal, MD 121 Medical Center Dr Ste 3100, Brunswick, ME 04011-2672 Ph: (207) 406-7310 |
News Archive
A promising new therapy for rheumatoid arthritis (RA) developed by researchers at the University of California, San Diego (UCSD) School of Medicine re-educates the body's immune system to prevent an attack against healthy joint tissue.
Coastal Contacts Inc. today announced that it has entered into a loan agreement with the Bank of America for a $5 million secured revolving line of credit.
The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK's Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today (09 February 2011).
Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its intention to sell US$500 million of senior unsecured notes due 2021 issued by Fresenius Medical Care US Finance, Inc. and €300 million of senior unsecured notes due 2021 issued by FMC Finance VII S.A..
Scientists at the Johns Hopkins Kimmel Cancer Center have identified a molecular partnership in pancreatic cancer cells that might help to explain how the disease spreads — metastasizes — in some cases. Their findings reveal urgently needed new targets to treat pancreatic cancer, which strikes nearly 50,000 people in the U.S. each year and has only a 5 percent survival rate five years after diagnosis.
› Verified 3 days ago
George Richard Polkinghorn, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 81 Medical Center Dr, Suite 1300, Brunswick, ME 04011 Phone: 207-729-1148 Fax: 207-729-2789 | |
Miguel R Arguedas - Brollo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Suite 3400, Brunswick, ME 04011 Phone: 207-406-7300 Fax: 207-406-7301 | |
Dr. Peter Westervelt, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 329 Maine St, Brunswick, ME 04011 Phone: 207-373-2266 Fax: 314-454-5902 | |
Dr. Thomas Blake Hendrix, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Jeremy Leonard Hardison, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 121 Medical Center Dr, Brunswick, ME 04011 Phone: 207-661-2018 | |
Deanna L Pouliot, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 123 Medical Center Dr, Brunswick, ME 04011 Phone: 207-373-6000 | |
Dr. Timothy R Howe, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 329 Maine St, Suite D, Brunswick, ME 04011 Phone: 207-725-2429 Fax: 207-721-9345 |